🧬 Noam Solomon - Immunai - Part 4 | How Searching for Investors is Like Finding a Life Partner | Luck In Fundraising | The Optimal Features of the Immune System | The Advice to Take More Risks
August 22, 2024
Part 4 of 4.
My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 4 of 4.
Part 4 of 4.
My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
Prior to co-founding Immunai, Noam had a career in both industry and academia. Noam has a double PhD in math and computer science and served as a postdoctoral researcher at MIT and Harvard. Noam also worked as an algorithms developer, consultant, and head of data science in several high-tech companies in Israel. Noam's extensive background in math, computer science, AI, and machine learning gives him a unique depth of experience that founders can learn from.
Join us this week and hear about:
- Noam's unique dynamics of working with academic institutions and the alignment of incentives that come with collaborating with top researchers
- The importance of strategic partnerships and the meticulous analysis involved in selecting the right collaborators
- Noam’s fundraising journey
- The technological advancements at Immunai
- The application of AI in optimizing drug development processes
Please enjoy my conversation with Noam Solomon.
Timestamps:
Timestamps:
00:00 Intro
01:35 Episode starts, screening for the right business partners and determining what projects to take on and which ones to pass
07:40 Noam’s philosophy and tips on fundraising
15:47 What to expect of Immunai in the next year or two
19:30 Shout outs for help along his journey
21:47 Advice to your 21-year old self
24:15 Outro
Find Our Guest, Noam Solomon, at this link:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Enriched Notes:
Topics Mentioned:
Biotech Startup Support https://www.excedr.com/resources-category/biotech-startup-support
Biotech Funding for Startups: What Are Your Options? https://www.excedr.com/resources/biotech-startup-funding-options
How to Get Funding for Lab Research in 2024 https://www.excedr.com/blog/how-to-get-funding-for-lab-research
How to Raise Money from Angel Investors https://www.excedr.com/resources/angel-funding-and-angel-investors
What Is Series A, B, & C Funding? Series Funding Explained https://www.excedr.com/resources/series-funding-explained
How to Fund an R&D Startup: First Steps a Founder Can Take https://www.excedr.com/resources/rd-startup-funding-first-steps
Biotech Partnerships: How Partnering with Big Pharma Can Support R&D https://www.excedr.com/blog/how-biotech-partnerships-support-research
What Should Investors & Founders Expect From Each Other? https://www.excedr.com/resources/investor-founder-expectations
People Mentioned
Luis F. Voloch https://www.linkedin.com/in/luisvoloch/
Ansu Satpathy https://www.linkedin.com/in/ansu-satpathy-67a5a9193/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so